Minivelle

Short answer: for most people who need systemic estrogen, the transdermal route (patch or gel) is generally safer than oral estrogen—especially with regard to blood clots (venous thromboembolism) and some liver/metabolic effects. Why: Oral estrogens go through the liver first (“first‑pass”), which raises clotting factors, increasing VTE risk (and can raise triglycerides and affect CRP). Multiple studies and meta‑analyses show oral menopausal estrogen is associated with a higher VTE risk than transdermal. Transdermal estradiol (patch or gel) delivers hormone directly into the bloodstream, avoids the first‑pass hepatic effect, gives steadier blood levels, and is not associated with the same increase in VTE risk in observational studies. Oral estrogen may also increase gallbladder disease more than transdermal. Both routes carry other risks that depend on dose, whether a progestin is also used (required if you have a uterus), age, time since menopause, and personal risk factors (smoking, obesity, prior clots, thrombophilia, stroke, active cancer). Practical choices (brand examples): Transdermal patches: Climara, Vivelle‑Dot (Evra in some countries), Alora, Minivelle — commonly used for lower VTE risk and steady estradiol levels. Transdermal gels/solutions: EstroGel, Divigel — alternatives if you don’t like patches. Oral tablets: Estrace (micronized estradiol) or Premarin (conjugated equine estrogens) — used widely but have higher hepatic effects than transdermal. Other important points: If you have a history of VTE, known thrombophilia (e.g., factor V Leiden), recent stroke, or active liver disease, systemic estrogen may be contraindicated — and transdermal is usually preferred over oral only after specialist input. If you have a uterus, you’ll usually need a progestogen as well to prevent endometrial hyperplasia. Micronized progesterone (Prometrium) is often used and may have a different side‑effect profile than some synthetic progestins. Use the lowest effective dose for the shortest time needed and review periodically. Avoid unregulated “compounded bioidentical” products unless closely supervised (they’re not FDA‑standardized). Next step: discuss your personal medical history (age, smoking, clot history, cardiovascular risk, family history of thrombosis or breast cancer, whether you still have your uterus) with your clinician to choose route, dose, and whether you need progestogen. I can help you list questions to bring to your provider or summarize risks based on specific personal factors if you want.

Mentioned in position 5 of 10

Short answer “Bioidentical” hormones are hormones that have the same molecular structure as the hormones made by the human body (for example 17β‑estradiol or micronized progesterone). “Standard” (conventional) HRT usually refers to FDA‑approved products that may be bioidentical (some are) or non‑bioidentical/synthetic (e.g., conjugated equine estrogens, medroxyprogesterone). The important point: being labeled “bioidentical” does not automatically make a product safer or more effective than standard, FDA‑approved HRT. There is little evidence that compounded bioidentical preparations are safer or work better. Definitions and practical differences Bioidentical hormones: Chemical structure matches human hormones (examples: 17β‑estradiol, progesterone). Can be prescribed as FDA‑approved products (e.g., estradiol patches, oral estradiol, micronized progesterone) or made by compounding pharmacies into custom creams, gels, capsules, or pellets. Compounded bioidentical formulations are promoted as “custom” but are not reviewed by the FDA for quality, purity, dose consistency, or proven safety/efficacy. Standard/conventional HRT: Usually means FDA‑approved hormone products with established manufacturing standards and clinical-trial data about benefits and risks. May include bioidentical molecules (e.g., estradiol) or non‑bioidentical molecules (e.g., conjugated equine estrogens like Premarin; synthetic progestins like medroxyprogesterone acetate/Provera). Evidence and safety Major medical societies (North American Menopause Society, ACOG, Endocrine Society) say there is no convincing evidence that compounded bioidentical hormones are safer or more effective than FDA‑approved HRT. Risks are similar across formulations and include increased risk of blood clots, stroke, and — depending on type, dose and duration — possibly breast cancer. Benefits include relief of hot flashes, night sweats, improved sleep and vaginal/urethral symptoms, and protection against bone loss. FDA‑approved products have better quality control and known dosing; compounded products can have variable concentrations and lack large randomized trial data. “Hormone testing” (saliva tests or spot blood tests) used by some compounding clinicians to “customize” dosing is often not reliable for guiding systemic HRT. Delivery formats (examples) Patches: Vivelle‑Dot, Climara, Minivelle (estradiol patches). Good for steady dosing; may have lower clot risk than some oral estrogens. Oral estradiol: Estrace (estradiol tablets). Conjugated estrogens: Premarin (established product used in older trials). Vaginal/local: Vagifem (estradiol tablet), Estring (vaginal ring) — good for local vaginal symptoms with less systemic exposure. Progesterone: Prometrium (micronized progesterone; bioidentical and FDA‑approved) vs synthetic progestins such as medroxyprogesterone acetate (Provera). Compounded options: custom creams, gels, pellets (brands/practices such as pellet therapy companies exist, e.g., BioTE-style pellet programs). These are popular but less well studied and regulated. How to choose Talk with your clinician about goals (relief of vasomotor symptoms, vaginal symptoms, bone protection), medical history (breast cancer, blood clots, liver disease), and personal risk factors. Prefer FDA‑approved products when possible — they have known dosing, consistent manufacturing, and clinical trial data. If considering compounded bioidentical HRT, ask the prescriber why they prefer it over approved options, whether the compounding pharmacy follows USP <795/797> standards, and how dosing will be monitored. Use the lowest effective dose for the shortest duration needed, and revisit treatment regularly. If you’ve had a hysterectomy you generally do not need progestin; if you have a uterus you usually need progestin or an approved combined regimen to protect the endometrium. Bottom line “Bioidentical” describes molecular identity, not safety or evidence. FDA‑approved estradiol and micronized progesterone are bioidentical and are preferable to unregulated compounded mixes for most people because of known dosing and quality. Discuss options with your clinician, considering personal risks, and don’t rely on unvalidated testing or marketing claims. If you’d like, tell me your age, symptoms, and medical history (history of clotting, breast cancer, liver disease, smoking) and I can outline reasonable options to discuss with your clinician.

Mentioned in position 3 of 10

Short answer There’s no single “best” delivery method — pellets, creams/gels and patches each have tradeoffs. The right choice depends on which hormones you need, how stable you want blood levels, how adjustable you want dosing, your medical risks (clotting, breast cancer, liver disease), and your tolerance for minor procedures. For steady, infrequent dosing choose pellets; for an FDA‑standard, predictable transdermal option choose patches; for flexible dosing or topical/local effects choose creams/gels — but be aware creams have the most absorption variability and transfer risk. Talk with a menopause specialist or your clinician and get appropriate baseline labs and follow‑up. What each type does, plus pros/cons Pellets (subcutaneous implants) What: Solid pellets (usually estradiol and/or testosterone) are placed under the skin every ~3–6 months and release hormone continuously. Pros: Very steady hormone levels, no daily dosing, good for people who dislike daily meds. Cons: Minor surgical procedure to insert/remove, risk of infection or pellet extrusion, dose is not easily changed once inserted, many pellets are compounded (variable quality). Not ideal if you expect to need rapid dose changes. Who offers it: BioTE (large network/training company), SottoPelle (clinician network specializing in pellet therapy), and many anti‑aging/menopause clinics and some telemedicine clinics (e.g., certain specialty providers such as Defy Medical offer pellet services). Patches (transdermal patches) What: Adhesive patches that deliver estradiol (and commercially in men, testosterone) through the skin. Pros: Predictable, FDA‑approved options for estradiol (good systemic control), lower risk of first‑pass liver effects than oral hormones, dose adjustments are straightforward, no insertion procedure. Cons: Skin irritation, patches can fall off, visible, need regular application/change. Common FDA‑approved brands (mostly for estradiol): Vivelle‑Dot, Climara, Alora, Minivelle, Menostar. For testosterone in men: Androderm/AndroGel (testosterone gels/patches are typically for men; women’s testosterone is often compounded). Creams/gels (topical/transdermal) What: Hormone gels or creams rubbed on the skin or used vaginally (vaginal creams deliver local effects with lower systemic exposure). Pros: Easy to start/stop and change dose, can be compounded to individualized doses, good for local vaginal symptoms (vaginal estradiol creams like Estrace are FDA‑approved for local use). Cons: Highly variable absorption between people and sites of application, higher risk of transferring hormone to others by skin contact, many preparations are compounded (variable quality), systemic levels can be unpredictable requiring careful monitoring. Brands/services: Estrace cream (vaginal estradiol, FDA‑approved). For systemic “bioidentical” creams many providers use compounding pharmacies (see below). Safety/regulatory notes “Bioidentical” simply means chemically identical to human hormones (estradiol, progesterone, testosterone). Some FDA‑approved products use bioidentical hormones (e.g., estradiol patches/gels, oral micronized progesterone [Prometrium], vaginal estradiol creams). However, many BHRT creams and pellets are compounded — compounding is not FDA‑standardized and product potency/sterility can vary. Because pellets are often compounded and implantation is a minor surgical procedure, you should choose an experienced provider and discuss infection/other risks. Hormone therapy decisions must consider personal history (breast cancer, clotting disorders, cardiovascular disease, liver disease). Always review risks/benefits with a clinician. Who to see / where to get them For patches/approved topical products: see your primary care, OB/GYN, or menopause clinic — they can prescribe FDA‑approved patches (Vivelle‑Dot, Climara), estradiol gels, or oral progesterone (Prometrium). For pellets: look for clinicians affiliated with pellet networks (BioTE, SottoPelle) or experienced menopause/anti‑aging clinics. Ask about training, complication rates, and follow‑up protocols. For compounded creams/gels: use a reputable compounding pharmacy (look for accreditation such as PCAB accreditation or USP compliance). Examples of widely known compounding pharmacies include Wedgewood Pharmacy and Empower Pharmacy (ask your clinician for local recommendations). Telemedicine clinics that specialize in hormone therapy can arrange testing and prescriptions but verify they use accredited labs and safe compounding/implantation practices. Practical guidance to choose Decide goals: systemic symptom control (hot flashes, mood, libido) vs local vaginal symptoms vs testosterone replacement. Consider convenience: pellets = low maintenance; patches = weekly/daily routine; creams = daily and more user‑dependent. Consider adjustability: patches/creams easier to titrate than pellets. Consider safety/history: if you have clot risk or breast cancer history, discuss alternatives and risks with a specialist. If using compounded products, insist on an accredited pharmacy and documented lab testing and follow‑up. If you’d like, tell me: Which hormones you’re considering (estradiol, progesterone, testosterone)? Any medical history (blood clots, breast cancer, liver disease, migraines)? Whether you prefer fewer clinic visits or maximal dose control? I can then suggest the most appropriate route and name specific clinics or products in your area or online.

Mentioned in position 7 of 14

BHRT Delivery Methods: A Practical Comparison Pellets Best for: Consistent levels, low-maintenance people Inserted under skin every 3-6 months Very steady hormone levels (no daily fluctuations) Providers: BioTE (largest network, thousands of certified practitioners), SottoPelle, EvexiPEL Downside: Invasive, can't adjust dose quickly if problems arise Creams/Gels Best for: Flexibility and dose adjustment Applied daily to skin Easy to modify or stop Providers: Winona (telehealth, ships to most states), Alloy Women's Health, compounding pharmacies like Belmar Pharmacy or Farmacy through your doctor Downside: Transfer risk to partners/children, absorption varies Patches Best for: Convenience with some flexibility Changed 1-2x weekly Most studied delivery method with established safety data Brands: Vivelle-Dot, Climara, Minivelle (FDA-approved options) Providers: Available through most OB-GYNs, Midi Health (telehealth), Gennev Quick Recommendations Priority Choose Convenience Pellets (BioTE) Flexibility Creams (Winona) Evidence-based Patches (Midi Health) Important: Consult a hormone-specialist physician — individual health history matters significantly.

Mentioned in position 10 of 12

Short answer: there’s no single “best” BHRT delivery method — each has pros and cons. The right choice depends on which hormone you need (estradiol, progesterone, testosterone), your symptom goals, medical history, how easily you want to change dose, and safety concerns. Below is a concise comparison, who commonly supplies each option, and practical advice. Basic comparison Pellets (subcutaneous pellets implanted every 3–6 months) Pros: steady, long‑acting release; good adherence (no daily dosing). Cons: minor in‑office procedure for insertion/removal, dose isn’t easily adjusted between insertions, risk of infection/expulsion, more often offered as compounded formulations (variable regulation). Common providers/brands: BioTE Medical, SottoPelle, EvexiPEL (clinics/networks that train providers and supply pellets). Many anti‑aging or hormone clinics offer pellet therapy. Creams/gels (topical, usually applied daily) Pros: flexible dosing and easy to stop/change; topical application avoids first‑pass liver metabolism (for systemic products); convenient. Cons: variable absorption between people and sites of application; risk of inadvertent transfer to others (skin‑to‑skin); many preparations are compounded (less standardized). Common sources: compounded testosterone or progesterone creams from compounding pharmacies such as Wedgewood Pharmacy, Fagron, Empower Pharmacy. FDA‑approved transdermal gels (mostly for men’s testosterone) include AndroGel, Testim; estradiol gels include Divigel (systemic estradiol). Patches (transdermal matrix patches replaced on a schedule) Pros: steady, more predictable systemic delivery than many creams; non‑invasive and easy to use; transdermal estradiol patches appear to have lower risk of clotting than oral estrogens. Cons: possible skin irritation; visible; some hormones (e.g., testosterone for women) don’t have widely accepted FDA patches and may be compounded or off‑label. Common brands: Vivelle‑Dot, Climara, Alora, Minivelle, Menostar (all estradiol patches). Androderm is a testosterone patch for men. Safety/regulatory notes “Bioidentical” describes hormones chemically identical to human hormones. Some bioidentical products are FDA‑approved (e.g., 17β‑estradiol patches, micronized progesterone/Prometrium); many custom “BHRT” products (creams, some pellets) are compounded and not FDA‑regulated to the same standard. Transdermal routes (patch/gel) generally avoid first‑pass liver metabolism and are associated with lower effects on clotting factors than oral estrogen; pellets and creams can produce systemic levels but evidence on long‑term safety of compounded pellets is limited. If you have a history of breast cancer, blood clots, active liver disease, or certain cardiovascular conditions, some forms of hormone therapy may be contraindicated — discuss this with your clinician. Who offers them (practical list) Pellets: BioTE Medical, SottoPelle, EvexiPEL (clinic networks that place pellets). Patches (estradiol): Vivelle‑Dot, Climara, Alora, Minivelle, Menostar (available by prescription through mainstream physicians). Gels/creams (systemic estradiol/testosterone): Divigel (estradiol gel, prescription), AndroGel/Testim (testosterone gel for men). For women’s testosterone or custom estrogen/progesterone creams, many providers use compounding pharmacies (Wedgewood, Fagron, Empower, etc.). Clinics that commonly offer multiple BHRT options: many integrative/anti‑aging clinics and some primary care/gynecology practices (e.g., BioTE‑certified clinics, SottoPelle clinics, private hormone clinics such as Defy Medical and similar practices). Always check clinician credentials and treatment protocols. How to choose If you want steady, low‑maintenance levels and don’t mind a procedure: pellets may be attractive. If you want easy dose adjustments and short‑term trials: creams/gels are flexible (but watch absorption and transfer risk). If you want predictable, noninvasive systemic delivery with good dosing control: patches or FDA‑approved gels are often a good middle ground. Prefer FDA‑approved products when available; if using compounded BHRT, use a reputable compounding pharmacy and a clinician who orders appropriate labs and follow‑up. Next steps Talk with a clinician experienced in hormone therapy (ob/gyn, endocrinologist, or a primary care clinician with BHRT experience). Ask about: which hormones you need, baseline labs, how they monitor levels/symptoms, risks specific to you, and whether they use FDA‑approved vs compounded products. If you want names of nearby clinics or pharmacies, tell me your city/ZIP and which hormone(s) you’re interested in and I can list local options and what they offer.

Mentioned in position 13 of 17

Short answer: for most women, transdermal estrogen (patch, gel) is generally safer than oral estrogen with respect to blood-clot risk and some liver-mediated effects. Which is “safer” for you depends on your age, medical history, cancer risk, smoking status, and other medicines — so discuss it with your clinician. Why transdermal is often preferred Lower risk of venous thromboembolism (VTE): oral estrogens go through the liver first (“first‑pass” effect) and raise clotting factors; multiple studies and meta‑analyses show oral estrogen is associated with a higher VTE risk than transdermal. This is important if you have prior clots, a known clotting disorder, obesity, or are a smoker. Less effect on hepatic proteins and triglycerides: oral estrogen increases liver production of sex‑hormone binding globulin, clotting factors, and inflammatory markers; transdermal avoids much of that. Better for liver disease and some metabolic concerns: if you have impaired liver function or high triglycerides, transdermal is usually preferred. More stable blood levels and often fewer systemic side effects like nausea. When oral estrogen may be reasonable Lower cost or easier adherence for some people (pill vs managing a patch). Some women get adequate symptom control with oral formulations and have no contraindications. Oral estradiol or conjugated estrogens are effective; differences in breast cancer risk depend on dose, duration, and whether progesterone is also used. Other important safety points (both routes) If you still have a uterus, progestin must be added to prevent endometrial hyperplasia/cancer (options include oral micronized progesterone like Prometrium or a levonorgestrel IUD such as Mirena). Estrogen is contraindicated with current estrogen‑dependent cancer, active VTE, recent stroke or MI, and pregnancy. For breast‑cancer survivors you generally need to discuss with your oncologist; systemic estrogen is usually avoided, though low‑dose vaginal estrogen may sometimes be considered for severe GSM symptoms after specialist discussion. Patch side effects: skin irritation, possibility of patches falling off. Oral side effects: nausea, bloating, more liver effects. Brands/examples Patches: Vivelle‑Dot, Climara, Alora, Minivelle (estradiol patches). These are common transdermal estradiol products. Oral estrogens: Estrace (oral estradiol), Premarin (conjugated equine estrogens). Progestins/uterine protection: Prometrium (micronized progesterone), Provera (medroxyprogesterone acetate), Mirena IUD (levonorgestrel). Bottom line / recommendation If you have risk factors for blood clots (past VTE, known thrombophilia), obesity, smoking, or liver disease, transdermal estrogen is usually safer. If you have no contraindications and prefer a pill, oral estrogen is an option, but discuss the risks and choose the lowest effective dose for the shortest reasonable duration. Talk to your clinician to assess your individual VTE/CVD/breast cancer risk, and to decide on the estrogen type, dose, and need for progestin. If you want, tell me your age, whether you have a uterus, any personal or family history of clots, heart disease, or breast cancer, and whether you smoke — I can give more personalized guidance.

Mentioned in position 6 of 9